Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT06846736
ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study
Sponsor: Sheba Medical Center
View on ClinicalTrials.gov
Summary
The Goal of this observational study is to develop an AI-driven pathologic image analysis-based classifier that can identify patients unlikely to significantly benefit from the currently utilized first-line ALK inhibitors (advanced-generation ALK inhibitors). Our goal is a classifier with final ROC-AUC value of 0.75.
Official title: ALK Digital Pathology Outcome Prediction
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2023-08-13
Completion Date
2028-12-01
Last Updated
2025-02-26
Healthy Volunteers
No
Locations (1)
Sheba Medical Center
Ramat Gan, Israel